ID

30502

Description

Antidepressant Incomplete Response Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00782964

Link

https://clinicaltrials.gov/show/NCT00782964

Keywords

Versions (1)
  1. 6/9/18 6/9/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 9, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Major Depressive Disorder NCT00782964

English

Eligibility Major Depressive Disorder NCT00782964

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of written inform consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
diagnosed of major depressive disorder based on dsm-iv-tr
Description

Major Depressive Disorder

Data type

boolean

Alias
UMLS CUI [1]
C1269683
outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (ssri/nsri) 5
Description

Outpatients | Pharmacotherapy Plan Change | Status post Partial response | Intolerance to Antidepressive Agents Dosage | Intolerance to Selective Serotonin Reuptake Inhibitors | Intolerance to Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

Data type

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2,1]
C0013216
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C0443172
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1521726
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0003289
UMLS CUI [4,3]
C0178602
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0360105
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C1579361
able to understand and to comply with requirements of the study
Description

Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
mental retardation
Description

Mental Retardation

Data type

boolean

Alias
UMLS CUI [1]
C0025362
to have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
mdd secondary to substance abuse or somatic illness
Description

Major Depressive Disorder Secondary to Substance Use Disorders | Major Depressive Disorder Secondary to Illness Somatic

Data type

boolean

Alias
UMLS CUI [1,1]
C1269683
UMLS CUI [1,2]
C0175668
UMLS CUI [1,3]
C0038586
UMLS CUI [2,1]
C1269683
UMLS CUI [2,2]
C0175668
UMLS CUI [2,3]
C0221423
UMLS CUI [2,4]
C2986476
actual depressive episode with <4 weeks or >12 months of length
Description

Depressive episode Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0349217
UMLS CUI [1,2]
C0449238
current treatment with >1 ssri/srni or previous treatment with >1 ssri/srni, augmentation treatment with ssri/srni, intravenous antidepressant treatment, tms, ect or mao
Description

Selective Serotonin Reuptake Inhibitors Quantity | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) Quantity | Selective Serotonin Reuptake Inhibitors augmented | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) augmented | Antidepressive Agents Intravenous | Transcranial magnetic stimulation | Electroconvulsive Therapy | Monoamine Oxidase Inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0360105
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1579361
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C0360105
UMLS CUI [3,2]
C0205217
UMLS CUI [4,1]
C1579361
UMLS CUI [4,2]
C0205217
UMLS CUI [5,1]
C0003289
UMLS CUI [5,2]
C1522726
UMLS CUI [6]
C0436548
UMLS CUI [7]
C0013806
UMLS CUI [8]
C0026457
Back to the top of the page

Similar models

Eligibility Major Depressive Disorder NCT00782964

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
provision of written inform consent
boolean
C0021430 (UMLS CUI [1])
Major Depressive Disorder
Item
diagnosed of major depressive disorder based on dsm-iv-tr
boolean
C1269683 (UMLS CUI [1])
Outpatients | Pharmacotherapy Plan Change | Status post Partial response | Intolerance to Antidepressive Agents Dosage | Intolerance to Selective Serotonin Reuptake Inhibitors | Intolerance to Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Item
outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (ssri/nsri) 5
boolean
C0029921 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0443172 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C1521726 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0003289 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C1744706 (UMLS CUI [5,1])
C0360105 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C1579361 (UMLS CUI [6,2])
Protocol Compliance
Item
able to understand and to comply with requirements of the study
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Mental Retardation
Item
mental retardation
boolean
C0025362 (UMLS CUI [1])
Study Subject Participation Status
Item
to have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
boolean
C2348568 (UMLS CUI [1])
Major Depressive Disorder Secondary to Substance Use Disorders | Major Depressive Disorder Secondary to Illness Somatic
Item
mdd secondary to substance abuse or somatic illness
boolean
C1269683 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0038586 (UMLS CUI [1,3])
C1269683 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0221423 (UMLS CUI [2,3])
C2986476 (UMLS CUI [2,4])
Depressive episode Duration
Item
actual depressive episode with <4 weeks or >12 months of length
boolean
C0349217 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Selective Serotonin Reuptake Inhibitors Quantity | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) Quantity | Selective Serotonin Reuptake Inhibitors augmented | Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) augmented | Antidepressive Agents Intravenous | Transcranial magnetic stimulation | Electroconvulsive Therapy | Monoamine Oxidase Inhibitors
Item
current treatment with >1 ssri/srni or previous treatment with >1 ssri/srni, augmentation treatment with ssri/srni, intravenous antidepressant treatment, tms, ect or mao
boolean
C0360105 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1579361 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0360105 (UMLS CUI [3,1])
C0205217 (UMLS CUI [3,2])
C1579361 (UMLS CUI [4,1])
C0205217 (UMLS CUI [4,2])
C0003289 (UMLS CUI [5,1])
C1522726 (UMLS CUI [5,2])
C0436548 (UMLS CUI [6])
C0013806 (UMLS CUI [7])
C0026457 (UMLS CUI [8])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial